EUVIMEDSkopri EUVIMED
Übersichtsarbeit

Orphan nuclear receptors: structural mechanisms, ligand discovery, and therapeutic potential

Yunlong Liu, Shirong Wei, Ziheng Wang, Helian Yang, Zhongzhou Chen, Mengtian Ren, Xiuping Fu

Cellular Signalling · 2026-10 · 146 · 112653

DOI: 10.1016/j.cellsig.2026.112653 ↗

At a glance

Übersichtsarbeit in Cellular Signalling, 2026-10. Written by Yunlong Liu and 6 co-authors. Institution: School of Life Sciences, Tiangong University, Tianjin 300387, China. Major MEDLINE topics: Orphan Nuclear Receptors. Cited 2 times so far (Crossref); 106 references. Funded by: National Natural Science Foundation of China, National Key Research and Development Program of China.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Orphan nuclear receptors (ONRs) are members of the nuclear receptor superfamily initially identified without clearly defined endogenous high-affinity ligands. Nevertheless, increasing evidence demonstrates that they play essential roles in regulating metabolism, development, neural function, and tumorigenesis. Recent advances in structural biology, chemical biology, and systems biology have improved understanding of ligand recognition and regulatory mechanisms in these receptors. This review summarizes current progress in ONRs ligand research. ONRs are categorized according to their physiological roles in metabolic homeostasis, development and reproduction, and neuro-immune and cancer-related regulation, highlighting their involvement in diseases such as metabolic disorders, cancers, neurological diseases, and reproductive abnormalities. We discuss the structural basis of ligand recognition, focusing on conserved features of the ligand-binding domain (LBD) and structural variations, particularly in the α10 and AF-2 helices, that influence ligand accessibility and transcriptional regulation. Structural studies have revealed ligand-receptor complexes for representative ONRs, including ROR, HNF-4, REV-ERB, ERR, SF-1, and LRH-1, identifying ligand types such as lipids, heme, and phospholipids. In contrast, other receptors, including TR4, DAX-1, COUP-TFII, and Nur77, currently have only functional evidence supporting potential ligand interactions. Key strategies for ligand discovery include endogenous ligand co-purification, phenotype-based high-throughput screening, structural biology approaches, and structure-based virtual screening combined with molecular dynamics simulations. Major challenges include difficulties in endogenous ligand identification, context-dependent regulation, and limitations in achieving receptor subtype selectivity in drug development. Future progress will rely on integrating structural, biochemical, and multi-omics approaches to facilitate therapeutic targeting of ONRs.

Subjects

MeSH terms (MEDLINE)

Orphan Nuclear ReceptorsHumansLigandsAnimalsDrug Discovery

Author keywords

Ligand discovery strategiesLigand-binding domainOrphan nuclear receptorsStructural mechanismsTherapeutic potential

Substances

LigandsOrphan Nuclear Receptors

Authors and institutions

  • School of Life Sciences, Tiangong University, Tianjin 300387, China.
  • State Key Laboratory of Animal Biotech Breeding, College of Biological Sciences, China Agricultural University, Beijing 100193, China.
  • School of Life Sciences, Tiangong University, Tianjin 300387, China; Cangzhou Institute of Tiangong University, Cangzhou 061000, China. Electronic address: mengtianren@tiangong.edu.cn.
  • School of Life Sciences, Tiangong University, Tianjin 300387, China. Electronic address: fuxiuping@tiangong.edu.cn.

Funding

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Cite

APA

Liu, Y., Wei, S., Wang, Z., Yang, H., Chen, Z., Ren, M., & Fu, X. (2026). Orphan nuclear receptors: structural mechanisms, ligand discovery, and therapeutic potential. Cellular Signalling, 146, 112653. https://doi.org/10.1016/j.cellsig.2026.112653

Vancouver

Liu Y, Wei S, Wang Z, Yang H, Chen Z, Ren M, et al. Orphan nuclear receptors: structural mechanisms, ligand discovery, and therapeutic potential. Cellular Signalling. 2026;146:112653. doi:10.1016/j.cellsig.2026.112653

BibTeX
@article{Liu2026,
  author = {Liu, Yunlong and Wei, Shirong and Wang, Ziheng and Yang, Helian and Chen, Zhongzhou and Ren, Mengtian and Fu, Xiuping},
  title = {Orphan nuclear receptors: structural mechanisms, ligand discovery, and therapeutic potential},
  journal = {Cellular Signalling},
  year = {2026},
  volume = {146},
  pages = {112653},
  doi = {10.1016/j.cellsig.2026.112653}
}
Start for free →